Shenzhen New Industries Biomedical Engineering Past Earnings Performance
Past criteria checks 5/6
Shenzhen New Industries Biomedical Engineering has been growing earnings at an average annual rate of 19.4%, while the Medical Equipment industry saw earnings growing at 8% annually. Revenues have been growing at an average rate of 18.5% per year. Shenzhen New Industries Biomedical Engineering's return on equity is 21.7%, and it has net margins of 42.3%.
Key information
19.4%
Earnings growth rate
17.1%
EPS growth rate
| Medical Equipment Industry Growth | 16.0% |
| Revenue growth rate | 18.5% |
| Return on equity | 21.7% |
| Net Margin | 42.3% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Here's Why We Think Shenzhen New Industries Biomedical Engineering (SZSE:300832) Might Deserve Your Attention Today
Apr 09
The Returns On Capital At Shenzhen New Industries Biomedical Engineering (SZSE:300832) Don't Inspire Confidence
Mar 18Estimating The Fair Value Of Shenzhen New Industries Biomedical Engineering Co., Ltd. (SZSE:300832)
Mar 01Revenue & Expenses BreakdownBeta
How Shenzhen New Industries Biomedical Engineering makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 4,075 | 1,725 | 794 | 384 |
| 31 Dec 23 | 3,930 | 1,654 | 747 | 366 |
| 30 Sep 23 | 3,658 | 1,590 | 608 | 366 |
| 30 Jun 23 | 3,495 | 1,508 | 582 | 357 |
| 31 Mar 23 | 3,180 | 1,375 | 490 | 342 |
| 01 Jan 23 | 3,047 | 1,328 | 478 | 318 |
| 30 Sep 22 | 2,948 | 1,233 | 507 | 296 |
| 30 Jun 22 | 2,737 | 1,115 | 495 | 262 |
| 31 Mar 22 | 2,756 | 1,114 | 505 | 233 |
| 01 Jan 22 | 2,545 | 974 | 530 | 215 |
| 30 Sep 21 | 2,518 | 906 | 626 | 180 |
| 30 Jun 21 | 2,451 | 892 | 634 | 155 |
| 31 Mar 21 | 2,439 | 997 | 603 | 163 |
| 31 Dec 20 | 2,195 | 939 | 515 | 151 |
| 30 Sep 20 | 2,065 | 911 | 484 | 147 |
| 30 Jun 20 | 1,911 | 910 | 427 | 143 |
| 31 Mar 20 | 1,655 | 745 | 397 | 120 |
| 31 Dec 19 | 1,682 | 773 | 393 | 119 |
| 31 Dec 18 | 1,384 | 694 | 306 | 84 |
| 31 Dec 17 | 1,141 | 538 | 243 | 56 |
| 31 Dec 16 | 923 | 452 | 246 | 0 |
| 30 Sep 16 | 867 | 380 | 276 | 0 |
| 30 Jun 16 | 811 | 307 | 306 | 0 |
| 31 Mar 16 | 771 | 278 | 299 | 0 |
| 31 Dec 15 | 732 | 249 | 292 | 0 |
| 30 Sep 15 | 677 | 264 | 226 | 0 |
| 30 Jun 15 | 623 | 279 | 160 | 0 |
| 31 Mar 15 | 584 | 266 | 149 | 0 |
| 31 Dec 14 | 545 | 253 | 138 | 0 |
| 30 Sep 14 | 506 | 224 | 134 | 0 |
| 30 Jun 14 | 467 | 194 | 130 | 0 |
| 31 Mar 14 | 423 | 168 | 120 | 0 |
| 31 Dec 13 | 378 | 141 | 110 | 0 |
Quality Earnings: 300832 has high quality earnings.
Growing Profit Margin: 300832's current net profit margins (42.3%) are lower than last year (43.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300832's earnings have grown by 19.4% per year over the past 5 years.
Accelerating Growth: 300832's earnings growth over the past year (25.5%) exceeds its 5-year average (19.4% per year).
Earnings vs Industry: 300832 earnings growth over the past year (25.5%) exceeded the Medical Equipment industry -1.3%.
Return on Equity
High ROE: 300832's Return on Equity (21.7%) is considered high.